Literature DB >> 8673998

Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.

C Sperti1, C Pasquali, P Guolo, R Polverosi, G Liessi, S Pedrazzoli.   

Abstract

BACKGROUND: This study was performed to evaluate the utility of serum and cyst fluid analysis for enzymes (amylase and lipase) and tumor markers (carcinoembryonic antigen, CA 19-9, CA 125, and CA 72-4) in the differential diagnosis of cystic pancreatic lesions.
METHODS: Serum and cyst fluid were obtained from 48 patients with pancreatic cysts (21 pseudocysts, 14 mucinous cystic neoplasms, 6 ductal carcinomas, and 7 serous cystadenomas), observed between 1989 and 1994.
RESULTS: Serum CA 19-9 levels were significantly higher in ductal carcinomas (all > 100 U/mL) and mucinous cystic neoplasms (P < 0.05). CA 72-4 cyst fluid levels were significantly higher in mucinous cystic tumors (P < 0.005), with 95% specificity and 80% sensitivity in detecting mucinous or malignant cysts. A combined assay of serum CA 19-9 and cyst fluid CA 72-4 correctly identified 19 of 20 (pre-) malignant lesions (95%), with only 1 false-positive result (3.6%). Cytology showed a sensitivity of 48% and specificity of 100%.
CONCLUSIONS: Any pancreatic cyst with high serum CA 19-9 values, positive cytology, or high CA 72-4 in the fluid should be considered for resection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673998     DOI: 10.1002/(SICI)1097-0142(19960715)78:2<237::AID-CNCR8>3.0.CO;2-I

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  35 in total

Review 1.  Cystic lesions in the pancreas: when to watch, when to resect.

Authors:  J H Balcom IV; C Fernandez-Del Castillo; A L Warshaw
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 2.  Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions.

Authors:  Michael G Sarr; Michel Murr; Thomas C Smyrk; Charles J Yeo; Carlos Fernandez-del-Castillo; Robert H Hawes; Patrick C Freeny
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

3.  The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis.

Authors:  A Harlozinska-Szmyrka; M Strutynska-Karpinska
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

4.  Choledochal cyst or pancreatic (retention) cyst: a case report.

Authors:  Jon D Vogel; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

Review 5.  Endoscopic ultrasound advances, part 1: diagnosis.

Authors:  Edward Kim; Jennifer J Telford
Journal:  Can J Gastroenterol       Date:  2009-09       Impact factor: 3.522

6.  Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association.

Authors:  J Le Borgne; L de Calan; C Partensky
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 7.  EUS diagnosis of cystic lesions of the pancreas.

Authors:  B C Bounds; W R Brugge
Journal:  Int J Gastrointest Cancer       Date:  2001

Review 8.  Diagnosis and management of pancreatic cystic neoplasms.

Authors:  Mathew James Keegan; Bharat Paranandi
Journal:  Frontline Gastroenterol       Date:  2019-03-01

9.  Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytology.

Authors:  Lester J Layfield; Hormoz Ehya; Armando C Filie; Ralph H Hruban; Nirag Jhala; Loren Joseph; Philippe Vielh; Martha B Pitman
Journal:  Diagn Cytopathol       Date:  2014-04       Impact factor: 1.582

10.  Cystic pancreatic neoplasms: observe or operate.

Authors:  Kristine S Spinelli; Travis E Fromwiller; Roger A Daniel; James M Kiely; Attila Nakeeb; Richard A Komorowski; Stuart D Wilson; Henry A Pitt
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.